Premium
US drug and biologic approvals in 1997
Author(s) -
Beary John F.,
Siegfried John D.,
Tavares Renee
Publication year - 1998
Publication title -
drug development research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.582
H-Index - 60
eISSN - 1098-2299
pISSN - 0272-4391
DOI - 10.1002/(sici)1098-2299(199806/07)44:2/3<114::aid-ddr9>3.0.co;2-p
Subject(s) - food and drug administration , drug , drug approval , medicine , pharmacology , new drug application , medical prescription , approved drug , business
The Prescription Drug User Fee Act of 1992 enhanced review resources for the Food and Drug Administration (FDA). The past two years have seen an unprecedented approval of 92 new drugs and 19 new biologics. Information is provided on the 49 new products approved by the FDA in 1997. Drug Dev. Res. 44:114–129, 1998. © 1998 Wiley‐Liss, Inc.